Press Conferences
Embargo Policy for TCT® 2024
Please note that press conference presentations of late-breaking clinical trials and science at TCT® are held prior to the official presentations as a courtesy to the media. Embargoes do not lift until the start time of each individual trial presentation, as listed in the TCT® program. All embargo times are listed in Eastern Daylight Time (ET). This schedule is subject to change.
Monday, October 28, 2024
8:00 AM - 9:26 AM ET
8:00 AM
Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial
Philippe Genereux, MD
Embargo Lift Time: 10/28; 11:00 AM ET
8:12 AM
Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis
Mark R. Dweck, MD, PhD
Embargo Lift Time: 10/28; 11:22 AM ET
8:24 AM
Comparison of Noncompliant Balloon With Drug-Coating Balloon Angioplasties for Side Branch After Provisional Stenting for Patients With True Coronary BIFurcation Lesions: The Prospective, Multicenter, Randomized DCB-BIF Trial
Shao-Liang Chen, MD
Embargo Lift Time: 10/28; 2:00 PM ET
8:34 AM
Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial
Jing Chen, PhD
Embargo Lift Time: 10/28; 2:18 PM ET
8:44 AM
Comparison of Puncture Success Rate Between Distal Radial Access and Transradial Access in Patients With ST-Elevation Myocardial Infarction
Jun-Won Lee, MD, PhD
Embargo Lift Time: 10/28; 2:36 PM ET
8:54 AM
1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART Randomized Clinical Trial
David Erlinge, MD, PhD
Embargo Lift Time: 10/28; 2:54 PM ET
9:04 AM
Artificial-Intelligence Enabled Quantitative CT Assessment of Atherosclerosis and Major Adverse Events: The Multi-Center International CONFIRM2 Registry
Alexander Van Rosendael, MD, PhD
Embargo Lift Time: 10/28; 3:12 PM ET
9:14 AM
Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: The TAVR UNLOAD Trial
Nicolas M. Van Mieghem, MD, PhD
Embargo Lift Time: 10/28; 11:44 AM ET
Tuesday, October 29, 2024
8:00 AM – 9:38 AM ET
8:00 AM
ECLIPSE: A Large-scale, Randomized Trial of Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation
Ajay J. Kirtane, MD, SM
Embargo Lift Time: 10/29; 11:00 AM ET
8:12 AM
CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine Versus Placebo and Spironolactone Versus Placebo in Patients With Myocardial Infarction: The Results of the Colchicine Factorial
Sanjit S. Jolly, MD
Embargo Lift Time: 10/29; 11:22 AM ET
8:24 AM
Large-bore Mechanical Thrombectomy vs Catheter-directed Thrombolysis for Treatment of Intermediate-Risk Pulmonary Embolism: Primary Outcomes From the PEERLESS Randomized Controlled Trial
Wissam A. Jaber, MD
Embargo Lift Time: 10/29; 11:44 AM ET
8:36 AM
Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial
Ulf Teichgräber, MD, MBA
Embargo Lift Time: 10/29; 12:06 PM ET
8:48 AM
Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial
Thomas Pilgrim, MD
Embargo Lift Time: 10/29; 2:00 PM ET
8:58 AM
Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial
Tobias A. Rheude, MD
Embargo Lift Time: 10/29; 2:18 PM ET
9:08 AM
Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial
Raj Makkar, MD
Embargo Lift Time: 10/29; 2:36 PM ET
9:18 AM
Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials
Didier Tchetche, MD
Embargo Lift Time: 10/29; 2:54 PM ET
9:28 AM
The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation
Torsten P. Vahl, MD
Embargo Lift Time: 10/29; 3:12 PM ET
Wednesday, October 30, 2024
8:00 AM – 9:38 AM ET
8:00 AM
One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial
Michael J. Reardon, MD
Embargo Lift Time: 10/30; 11:25 AM ET
8:12 AM
Quantitative Flow Ratio or Fractional Flow Reserve for Guiding Coronary Revascularization
Niels R. Holm, MD
Embargo Lift Time: 10/30; 11:47 AM ET
8:24 AM
TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation
Suzanne V. Arnold, MD
Susheel K. Kodali, MD
Embargo Lift Time: 10/30; 11:00 AM ET
8:36 AM
Artificial Intelligence-Based Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation (FLASH): Multicenter, Randomized Controlled Non-Inferiority Trial
Jung-Min Ahn, MD
Embargo Lift Time: 10/30; 12:09 PM ET
8:48 AM
Outcomes of Percutaneous Mechanical Aspiration in Right-Sided Infective Endocarditis: The CLEAR IE Multicenter Registry
Abdallah El Sabbagh, MD
Embargo Lift Time: 10/30; 2:36 PM ET
8:58 AM
The TARGET-IV Trial: International Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System
Olivier F. Bertrand, MD, PhD
Embargo Lift Time: 10/30; 2:00 PM ET
9:08 AM
Prospective, Multicenter, Open-Label, Randomized Controlled Trial of 3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial
Hongbo Yang, MD
Embargo Lift Time: 10/30; 2:18 PM ET
9:18 AM
CLASP IID Randomized Trial and Registry: Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation
Scott Lim, MD
Firas Zahr, MD
Embargo Lift Time: 10/30; 2:54 PM ET
9:28 AM
Transcatheter Repair Versus Surgery in Atrial Mitral Regurgitation: Results From the MATTERHORN Trial
Stephan Baldus, MD
Embargo Lift Time: 10/30; 3:12 PM ET